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Self-renewal of human embryonic stem cells requires insulin-like growth factor-1
receptor and ERBB2 receptor signaling
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3Invitrogen, Carlsbad, CA; 4Department of Comparative Medicine, University of Washington, Seattle; 5Division of Medical Genetics, Department of Medicine,
University of Washington, Seattle; 6Department ofAnimal and Dairy Science, University of Georgia,Athens; 7Department of Pathology, College of Veterinary
Medicine, University of Georgia,Athens; and 8Novocell, San Diego, CA
Despite progress in developing deﬁned
conditions for human embryonic stem
cell (hESC) cultures, little is known about
the cell-surface receptors that are acti-
vated under conditions supportive of
hESC self-renewal. A simultaneous inter-
rogation of 42 receptor tyrosine kinases
(RTKs) in hESCs following stimulation
with mouse embryonic ﬁbroblast (MEF)
conditioned medium (CM) revealed rapid
and prominent tyrosine phosphorylation
of insulin receptor (IR) and insulin-like
growth factor-1 receptor (IGF1R); less
prominent tyrosine phosphorylation of
epidermal growth factor receptor (EGFR)
family members, including ERBB2 and
ERBB3; and trace phosphorylation of ﬁ-
broblast growth factor receptors. Intense
IGF1R and IR phosphorylation occurred
intheabsenceofMEFconditioning(NCM)
and was attributable to high concentra-
tions of insulin in the proprietary Knock-
Out Serum Replacer (KSR). Inhibition of
IGF1R using a blocking antibody or lenti-
virus-deliveredshRNAreducedhESCself-
renewal and promoted differentiation,
while disruption of ERBB2 signaling with
the selective inhibitor AG825 severely
inhibited hESC proliferation and pro-
moted apoptosis. A simple deﬁned me-
dium containing an IGF1 analog, heregu-
lin-1 (a ligand for ERBB2/ERBB3),
ﬁbroblast growth factor-2 (FGF2), and ac-
tivin A supported long-term growth of
multiple hESC lines. These studies iden-
tify previously unappreciated RTKs that
support hESC proliferation and self-
renewal, and provide a rationally de-
signed medium for the growth and main-
tenance of pluripotent hESCs. (Blood.
2007;110:4111-4119)
© 2007 by TheAmerican Society of Hematology
Introduction
In guiding human embryonic stem cell (hESC) technology
toward the clinic, 1 key issue to be addressed is a lack of
standardization in the culture and maintenance of hESCs. In the
absence of mouse embryonic ﬁbroblast (MEF) feeder layers,
many researchers rely on “conditioning” in which medium is
ﬁrst exposed to MEFs to acquire soluble factors that support the
propagation of undifferentiated hESCs in culture. It has been
difﬁcult to discern how MEF conditioning enables hESCs to
maintain an undifferentiated state. Other common features of
more recently developed hESC culture conditions include the
presence of ﬁbroblast growth factor-2 (FGF2), the absence of
serum, and the presence of a serum substitute such as KnockOut
Serum Replacer (KSR, proprietary formulation; Invitrogen,
Carlsbad, CA).1-3 Other factors suggested to play a role in
supporting the maintenance of hESCs include transforming
growth factor 1 (TGF1),4 activinA(ActA),5,6 platelet-derived
growth factor (PDGF) and sphingosine-1-phosphate,7 BIO, a
small-molecule inhibitor of GSK3,8 and neurotrophins.9 Sev-
eral deﬁned medium systems have been described for hESCs
and are based upon FGF2 in combination with nodal,10 TGF1,
GABA, and pipecolic acid, plus lithium chloride,11 Wnt3a plus
April/BAFF,12 or the N2/B27 supplements.13
Although these studies have focused on identifying growth
factors and conditions that support the proliferation of undifferenti-
ated hESCs, little is known about the cell-surface receptors that are
activated when hESCs are exposed to conditions favorable for
self-renewal. A number of receptor tyrosine kinases (RTKs) are
expressed at high levels on hESCs,14 including insulin-like growth
factor-1 receptor (IGF1R), ﬁbroblast growth factor receptor
(FGFR1), and EPHA1, as well as ERBB2 and ERBB3 (which are
members of the epidermal growth factor receptor [EGFR] family),
while expression of FGFR2 (EGFR) FGFR4, vascular endothelial
growth factor receptor-2 (VEGFR2), IGFR2, KIT, and RET has
also been detected.15,16 RTKs are likely to be central signaling
effectors17 that inﬂuence survival, apoptosis, proliferation, or
differentiation decisions in pluripotent cells. To determine if any of
these RTKs are involved in self-renewal, we simultaneously
interrogated the tyrosine phosphorylation status of 42 RTKs in
hESCs grown in MEF–conditioned medium (CM) and developed a
deﬁned medium for hESC culture.
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Cell culture
The National Institutes of Health (NIH)–registered H1, BG01, BG02, and
BG03 hESC lines, as well as CyT49, an hESC line isolated using human
feeder cells under good manufacturing process (GMP) conditions (Novo-
cell, San Diego, CA), were used in these experiments. Nonconditioned
medium (NCM) and CM were prepared as described previously,2 and
hESCs were maintained in CM on plates coated with Matrigel (BD
Biosciences, San Jose, CA) diluted 1:30, or in NCM on MEF feeder layers
where indicated. Cultures were routinely passaged with collagenase IV2 or
dispase.3 Karyotype analyses of hESCs grown in CM or deﬁned conditions
(DC) HAIF (Heregulin-1B, Activin A, Insulin like growth factor-1, FGF2)
were performed using standard G-banding techniques.
Culture of hESCs in deﬁned conditions
DC-HAIF consisted of DMEM/F12 (Invitrogen), 2% fatty acid-free Cohn
fraction V bovine serum albumin (BSA; Serologicals, Norcross, GA),
1  nonessential amino acids, 50 U/mLpenicillin, 50 g/mLstreptomycin,
50 g/mL ascorbic acid, 10 g/mL bovine or human transferrin, 0.1 mM
-mercaptoethanol (all from Invitrogen), 1 times trace elementsA, B, and C
(Mediatech, Manassas, VA), 10 ng/mL HRG1 (Peprotech, Rocky Hill,
NJ), 10 ng/mL ActA (R&D Systems, Minneapolis, MN), 200 ng/mL
LR3-IGF1 (JRH Biosciences, Lenexa, KS), and 8 ng/mL FGF2 (Sigma, St
Louis, MO) or R&D Systems). HESCs were cultured in DC-HAIF on
growth factor–depleted Matrigel (BD Biosciences) diluted 1:200. Near-
conﬂuent hESC cultures were passaged by treating with 10 mg/mL
(approximately 2000 U/mL) collagenase IV for 3 minutes, washing with
0.2% BSA in DMEM/F12, and gently scraping to lift and break up the
colonies. Colony pieces were centrifuged at 200g, aspirated, gently
resuspended in DC-HAIF, and typically split 1:3 to new plates. The
formulation of DC-HAIF is shown in Table S1 (available on the Blood
website; see the Supplemental Materials link at the top of the online article);
a detailed protocol for the maintenance of hESCs in DC-HAIF is available
in Document S1. Cell- and colony-counting experiments, the generation
and analysis of teratomas, embryoid bodies, and deﬁned differentiation to
endodermal lineages are detailed in Document S1.
Human RTK arrays
Proteome Proﬁler human phospho-RTK antibody arrays (R&D Systems)
were used according to the manufacturer’s instructions (Figure S1;
Document S1). A total of 500 g fresh protein lysates were incubated
overnight with nitrocellulose membranes dotted with duplicate spots for 42
anti-RTK and control antibodies. Bound phospho-RTKs were detected with
a pan antiphosphotyrosine antibody conjugated to horseradish peroxidase
using chemiluminescence.
Receptor inhibition studies
For experiments using the IGF1R blocking antibody, H1 hESCs were
incubated with 10 g/mLA12 (ImClone, NewYork, NY) or control human
IgG (Sigma) in CM. IGF1R expression was evaluated by ﬂow cytometry
after 4 hours of incubation with A12 or control antibody. Colonies were
counted and graded morphologically on the indicated days (Document S1;
Figure S2). Both differentiation and apoptosis were evaluated 3 days after
the addition of A12. Morphologic assessment of differentiation was
conﬁrmed by SSEA3 staining using ﬂow cytometry, and apoptosis was
assessed by TUNEL staining. Inhibition of ERBB2 with AG825 (Calbio-
chem, San Diego, CA) used hESCs growing in CM on Matrigel diluted 1:30
(Document S1). Cell-cycle and apoptosis assays were performed after
4 days of culture in CM plus eitherAG825 or DMSO (control).
Flow cytometry, RT-PCR analysis, and immunoﬂuorescence
Flow cytometry analyses or sorting were performed using a FACScan,
FACSCanto, or FACSAria cell sorter (BD Biosciences).The FlowTACS kit
(R&D Systems) was used to detect apoptotic cells, according to the
manufacturer’s instructions.Antibodies used to detect cell-surface antigens
for ﬂow and other immunoﬂuorescence analyses are described in Document
S1. Cell-cycle and DNA content analysis was performed using propidium
iodide staining and analysis with the Modﬁt 3.0 software (Verity House
Software, Topsham, ME). Immunostaining of cell cultures used secondary
antibodies conjugated with Alexa-488 (green) or -594 (red) (Invitrogen).
Nuclei were counterstained with DAPI (Sigma). Stained slides were
mounted with Aqua Poly/Mount (Polysciences, Warrington, PA) and
images were captured using Nikon TE2000-S and -E inverted microscopes
(Nikon,Tokyo, Japan), Q-Imaging Retiga cameras (Qimaging, Surrey, BC),
and the Q-Capture imaging system. Histological sections were stained with
hematoxylin and eosin (Sigma), or with primary antibody followed by
detection with alkaline phosphatase tagged secondary and counterstaining
with hematoxylin. Slides were mounted with Permount (Biomedia, Foster
City, CA), and images were captured with an Olympus BX41 light
microscope (Olympus, Center Valley, PA), an Olympus DP70 digital
camera, and Image Pro Plus 6.0 software (MediaCybernetics, Bethesda,
MD). Images were processed withAdobe Photoshop 6.0 (Adobe, San Jose,
CA). Methods for RNA isolation, reverse transcription–polymerase chain
reaction (RT-PCR) analyses, and primer sets are described in Document S1.
ShRNA inhibition of IGF1R
Design and construction of the IGF1R-targeting shRNA lentivirus vector,
plasmid transfection, generation of viral supernatants, evaluation of titer,
and transduction of H1 hESCs are all described in Document S1.
Transduced cells were cultured for 22 days and evaluated periodically for
green ﬂuorescent protein (GFP) and IGF1R expression by ﬂow cytometry.
Illumina bead array and transcriptional analysis
Methods for the preparation of samples, labeling, hybridization, washing,
detection, and analysis have been described previously,18 and were carried
out according to the manufacturer’s instructions (Document S1). Analysis
was performed using parallel approaches described for other hESC
samples18 with Illumina Sentrix Human-6 Expression Beadchips containing
47 296 transcript probes (Illumina, San Diego, CA). NIH gene expression
omnibus (GEO) accession number-GSE6645.
Results
The phosphorylation status of 42 RTKs was simultaneously
interrogated in hESCs using a membrane array of primary antibod-
ies and detection with a pan-antiphosphotyrosine antibody (Figure
S1). H1 cells cultured on Matrigel were starved overnight with
DMEM/F12 and 0.5% BSA and then stimulated with CM for 5 or
15 minutes. Following overnight starvation, variable faint or
moderate phosphorylation of several receptors, including IR,
IGF1R, ERBB1 (EGFR), ERBB2, ERBB3, VEGFR2, and FGFR3,
was detected (Figure 1A,B). Striking induction of IGF1R and IR
phosphorylation occurred within 5 minutes of stimulation with
CM, and persisted at 15 minutes (Figure 1A). Similarly, phosphor-
ylation of ERBB2 increased at 5 minutes, and rose further at
15 minutes. ERBB1 and ERBB3 were also phosphorylated, but to a
lesser extent, at 15 minutes. CM stimulation also elicited faint but
consistent phosphorylation of FGFR3. A handful of receptors,
including Axl, VEGFR2, PDGFR, EPHA2, FGFR2, MER, and
Tie2 were phosphorylated faintly and inconsistently in response to
CM. Of note, phosphorylated derivatives of FGFR1, and the
neurotrophin receptors TRKB and TRKC, were not detected
following stimulation with CM.
To discriminate between effects mediated by components of
NCM and effects resulting from conditioning, receptor phosphory-
lation was compared after stimulating overnight-starved H1 cells
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ylation of IR and IGF1R, which implied that a component of the
base medium was responsible. This was attributable to insulin,
which exceeds 10 g/mL in 20% KSR (International Patent
Publication WO 98/30679; Invitrogen), and at 10 g/mL can
activate IGF1R (Figure S3).19,20 While low-level phosphorylation
of ERBB2, FGFR3, and VEGFR2 was also observed, the most
apparent differences in the phospho-RTK proﬁles of hESCs
stimulated with CM versus NCM was an increase in ERBB3
phosphorylation in response to CM in 1 experiment (Figure 1B),
and elevated ERBB1 phosphorylation in another (data not shown).
These results suggest that the elaboration of an EGFR family
ligand(s) may be a functionally important consequence of MEF
conditioning. Different EGF family members preferentially bind to
andactivatespeciﬁchomo-orheterodimersofERBB1toERBB4.21
While EGF and TGF signal via homodimers of ERBB1, or
heterodimers of ERBB1/2, activation of ERBB2/3 suggests the
presence of neuregulins,22 of which heregulin-1 (HRG; also
called neuregulin 1) is the best-characterized example.
The expression of IGF1R, IR, and ERBB receptors on hESCs
and expression of their ligands in MEFs was examined. RT-PCR
conﬁrmed expression of transcripts for IR, IGF1R, ERBB2, and
ERBB3 in hESCs, whereas ERBB1 appeared to be expressed at a
lower level, and ERBB4 was undetectable (Figure 1C; Figure S4).
Flow cytometry conﬁrmed homogeneous cell-surface expression
of IGF1R, IR, ERBB2, and ERBB3 on hESCs (Figure 1D).
Coexpression of OCT4, SSEA4, or SSEA3 with either IGF1R or
ERBB2 was demonstrated (Figure S5A,B). In a small percentage
of spontaneously differentiated cells ( 2% SSEA4, or OCT4
cells), the intensity of IGF1R or ERBB2 expression remained
constant (Figure S5A,B). MEFs expressed transcripts for IGF1,
IGF2, and HRG, as well as ADAM19 (Figure 1C; Figure S4),
which is capable of proteolytic shedding of bioactive ERBB2/3
ligands.23 IGF1 and IGF2 transcripts were also detected in hESCs
by RT-PCR (Figure 1C; Figure S4). Expression of components of
the IGF1R/IR- and ERBB-signaling pathways, including receptors,
certain ligands, and downstream processing and signaling mol-
ecules of the PI3 and MAPkinase pathways, was a common feature
of 7 hESC lines (Table S2). The PI3 and MAPkinase pathways can
also be activated by FGF receptor signaling.24 In addition, consis-
tent expression of SMAD1 to SMAD7 suggests a role for
ActA/TGF/BMPsignaling in regulating hESCs4,6,10 (Table S2).
To investigate IGF1R signaling in hESC self-renewal, the
effects of the IGF1R-blocking monoclonal antibody A1225 were
tested. Treatment with A12 reduced IGF1R expression on the cell
surface as described25 (Figure 2A). A12 blocked the expansion of
hESC cultures and induced a signiﬁcant rise in differentiation
(Figure 2B,C; Figure S2). While treatment with A12 markedly
inhibited the ability of hESCs to expand in culture, it did not induce
apoptosis as determined by TUNEL assay (Figure 2D). The role of
IGF1R was also examined in hESCs using lentiviral vectors
expressing shRNAs (Document S1). A total of 2 lentiviral vectors
containing a GFP reporter linked to either an IGF1R-targeted
shRNA or a noninhibitory control shRNA were used. Transfection
of the IGF1R-targeted vector caused a signiﬁcant reduction in
IGF1R mRNA in GFP H1 cells 48 hours after transfection
compared with either the GFP population, or GFP cells trans-
fected with the control vector (Figure 2E). To examine the effects
of IGF1R inhibition on long-term culture, H1 cells were transduced
with either the IGF1R-targeted or control vector lentivirus, and the
expression of both GFP and IGF1R was examined in transduced
cultures over a 3-week period (Figure 2F). At 24 hours after
transduction, both cultures contained a similar proportion of GFP
cells. The activity of the IGF1R knockdown vector was conﬁrmed
by an inverse correlation between GFP intensity and IGF1R levels
on the cell surface. In comparison, IGF1R expression remained
Figure 1. CM triggers IGF1R/IR and ERBB-family tyrosine phosphorylation in hESCs. (A) RTK array analysis of H1 cells stimulated by CM for 5 or 15 minutes. Tyrosine
phosphorylation of IGF1R/IR and lower-intensity phosphorylation of ERBB (EGFR) family members was observed consistently. (B) RTK analysis of H1 cells stimulated by NCM
and CM for 15 minutes. Increased ERBB3 phosphorylation was observed with CM stimulation. (C) RT-PCR analysis of IGF1, IGF2, IGF1R, and IR expression in H1 cells, and
IGF1 and IGF2 expression in MEFs; ERBB1-4 expression in BG03 cells (and BG01 and BG02 cells; Figure S4); and HRG andADAM19 expression in MEFs. Full-length gels
are presented in Figure S4 online. (D) Flow cytometry of IGF1R, IR, ERBB2, and ERBB3 expression in H1 cells.
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the control vector. The proportion of GFP, GFP/IGF1R,
GFP/IGF1R, and GFP/IGF1R cells in the control culture
remained constant over the course of the experiment. Conversely,
in cultures containing the IGF1R-targeted shRNA, the proportion
of GFP cells fell progressively and signiﬁcantly. These results
indicate that inhibition of IGF1R with a shRNA led to a competi-
tive disadvantage in transduced cells, conﬁrming a requirement for
IGF1R signaling in hESC survival and/or self-renewal.
A highly selective inhibitor of the ERBB2 tyrosine kinase,
tyrphostin AG825,26 was used to investigate the role of ERBB2 in
hESCs. AG825 signiﬁcantly inhibited proliferation of hESCs
growing in CM (Figure 2G). Cell-cycle analysis showed a decline
in cells in G1 phase, suggesting a delay in the G2-M transition
(Figure 2H,I), as well as a dose-dependent rise in apoptosis (Figure
2J). AG825 had no effect on SSEA3 expression when assayed by
cytometry, and viable hESCs could be maintained for more than
5 days (not shown). Western blotting demonstrated that AG825
inhibited autophosphorylation of ERBB2 at tyrosine 1248 in
starved/HRG-pulsed hESCs (Figure S6), consistent with the litera-
ture.26 These ﬁndings demonstrated that disruption of ERBB2
signaling severely inhibited hESC proliferation and induced
apoptosis.
In consideration of the roles of IGF1R and ERBB2 in self-
renewal, a deﬁned medium was assembled containing a combina-
tion of IGF1R and ERBB2 ligands. Since IGF1 and IGF2 elicit
extremely similar proﬁles of RTK phosphorylation (Figure S7),
LONG R3 IGF1 (LR3-IGF1), a GMP-grade recombinant human
IGF1 that does not bind insulin-like growth factor–binding proteins
(IGFBPs), was added to the medium. The ERBB2 ligand used in
the deﬁned medium was the EGF domain of HRG, an EGF family
member which induces activation of the ERBB2/3 heterodimer.22
Figure 2. Disruption of IGF1R and ERBB2 signaling inhibits hESC self-renewal. (A) Treatment of H1 cells with the A12 anti-IGF1R blocking antibody led to decreased
IGF1R expression on the cell surface as measured by ﬂow cytometry. (B) Colony counting showed that theA12 antibody inhibited H1 cell proliferation (left).Arrows indicate that
cultures were passaged on day 3 and 6. Cumulative colony counts increased in the presence of control antibody but not in the presence of A12. A12 also induced hESC
differentiation (right) as measured by colony morphology (also see Figure S2). Error bars here and in panels C-H,J are standard deviation (SD). Flow cytometry for (C) SSEA-3
expression conﬁrmedA12 treatment caused increased differentiation, but (D) not an increase in apoptosis. (E) Signiﬁcant reduction of IGF1R mRNAin the GFP population of
cultures transfected with an IGF1R-targeted shRNA, compared with either the GFP- population, or GFP cells transfected with a control shRNA. (F) Decline in the percentage
of GFP cells in H1 cultures (left) transduced with a lentiviral vector containing a shRNA targeting IGF1R, rather than a control shRNA. Middle panel shows ﬂow cytometry
proﬁlesthatindicatestableexpressionofIGF1RandpercentagesofcellsthatareGFPincontrolshRNA–transducedculturesondays1,12,and22,whileculturestransduced
with the IGF1R-targeted shRNAvector exhibited a decline in IGF1R expression and a reduction in GFP and GFP/IGF1R cells. Right panel shows the average percentage
of GFP cells at days 15, 19, and 22 was signiﬁcantly lower in the IGF1R-targeted shRNAtransduced culture. (G)Atotal of 50 MAG825 inhibited proliferation of BG02 hESCs
growing in CM. Triplicate cell counts from 2 independent experiments are shown. ...and - - - indicate pretreatment cell counts from experiments 1 and 2, respectively.
(H,I) Increasing concentrations of AG825 caused a dose-dependent reduction in the proportion of H1 hESCs in the G1 phase of the cell cycle, and (J) a moderate
dose-dependent rise in apoptosis.
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maintenance of pluripotent cells,1,3,6 were also included. A simple
feeder-, serum-, and KSR-free deﬁned medium providing basal compo-
nents (Table S1) supplemented with 10 ng/mL HRG,
10 ng/mLActA, 200 ng/mL LR3-IGF1, and 8 ng/mL FGF2 (DC-HAIF
medium) supported the long-term expansion of undifferentiated hESCs.
Cultures were initially expanded on Matrigel diluted 1:30, but could be
maintained successfully long-term on this substrate diluted 1:200 or
1:1000, or human extracellular matrix (ECM) such as serum or
ﬁbronectin (not shown). Undifferentiated BG01 and BG02 hESCs were
maintained in DC-HAIF for greater than 7 and 9 months, respectively.
CyT49, a hESC line isolated on human feeders under GMP conditions,
was also maintained using DC-HAIF for greater than 3 months (not
shown).EGFfamilyligandsthatactivateERBB1/1orERBB1/2butnot
ERBB2/3 signaling, namely EGF, heparin-binding EGF, and TGF,
were unable to substitute for HRG in supporting long-term hESC
expansion (not shown). In addition, neurotrophin-39could not substitute
for HRG to support hESCs in these deﬁned conditions (not shown).
HESC cultures could be passaged directly from feeder layers or CM
conditions into DC-HAIF, and exhibited minimal spontaneous differen-
tiation (Figure 3A). Colony and cell-counting assays conﬁrmed that
LR3-IGF1 and HRG played the major roles in self-renewal and
proliferation in the context of this deﬁned medium (Figure 3B,C), and
cultures could not be maintained without HRG beyond approximately 3
weeks (not shown).Adirect comparison of serial passaging in CM and
DC-HAIF demonstrated that along with providing a substantially
simpliﬁed approach, expansion of hESC cultures was markedly en-
hanced in DC-HAIF conditions compared with traditional methods
(Figure 3D).
Multiple approaches were used to conﬁrm the maintenance
of hESC characteristics in DC-HAIF conditions. Cultures
retained expression of transcriptional and cell-surface markers
Figure 3. Culture of hESCs in a deﬁned medium designed to stimulate IGF1R/IR and ERBB2/3 signaling. (A) Low (4 objective) and high (40 objective) magniﬁcation
phase contrast images of morphologically undifferentiated BG02 hESCs growing in DC-HAIF. Overlapping ﬁelds (dashed black borders) were aligned to image a
representative large colony. Scale bar equals 100 and 25 m, respectively. (B) Colony counting for serial passaging of CyT49 hESCs in different combinations of growth
factors. Starter cultures were growing on MEFs in NCM and the proportion of undifferentiated (f) and differentiated () colonies at each stage are indicated.Acombination of
all 4 factors was necessary to enable long-term maintenance of hESCs. Similar results were obtained with repeated experiments and other hESC lines. Panel B and C
abbreviations: H indicates 10 ng/mL HRG1;A, 10 ng/mLActA; I, 200 ng/mL LR3-IGF1; and F, 8 ng/mL FGF2. (C) Cell-counting analysis of the role of IGF1 and HRG in hESC
proliferation using BG02 cells (left panel). The mean cell number/well before the different growth factor combinations were applied on day 1 is indicated (... ). Cultures were
disaggregated and counted on day 7, and the mean and standard deviation were plotted. Right panel shows OCT4/DAPI immunostaining of a duplicate repeated experiment
(4 objective), which demonstrated that IGF1 and HRG signiﬁcantly increased the proportion of OCT4 cells compared withActA/FGF2 conditions. Scale bar equals 50 m.
(D) Direct comparison of CM and DC-HAIF growth conditions with serial passaging. BG03 cells growing on MEFs were passaged to CM and DC-HAIF conditions in parallel (p0
plates).Triplicate cell counts were performed at p1 to p3 and the split ratio–corrected total cell number was plotted (mean  SD). Split ratios were (CM, DC-HAIF): p0 (1:3, 1:3);
p1 (1:2, 1:3); and p2 (1:2, 1:2). Similar results were obtained with repeat experiments. (E) Maintenance of markers of undifferentiated cells in BG02 DC-HAIF p5 cells compared
with BG02 in CM by RT-PCR. (F) Positive immunoﬂuorescence of hESC markers in BG02 DC-HAIF p5 cells (10 objective). Scale bar equals 50 m. (G) Representative
G-banding of BG02 DC-HAIF p26 cells. (H) RTK blotting analysis of BG01 DC-HAIF hESCs starved of growth factors overnight; starved, then pulsed with DC-HAIF for
15 minutes; or steady-state cultures are shown (left panel). The mean and range of normalized relative intensity is plotted (right panel).
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analyses demonstrated the maintenance of euploidy (Figure 3G;
Table 1). RTK blotting revealed robust phosphorylation of
IGF1R, IR, ERBB2, and ERBB3 in steady-state cultures and a
strong response in phosphorylation of these receptors when
starved cultures were pulsed with DC-HAIF. FGFR2 was also
phosphorylated, but to a lesser extent, in these experiments
(Figure 3H). Transcriptional analyses were used to compare
global expression in hESCs cells18 maintained in CM and
DC-HAIF (Table S3; full dataset). More than 11 600 transcripts
were detected in BG02 cells grown in DC-HAIF for 10 and
32 passages, or in CM for 64 passages, with 10 364 transcripts
common to all populations (Figure 4A), including known hESC
markers such as CD9, DNMT3, NANOG, OCT4, TERT, and
UTF1 (not shown). High-correlation coefﬁcients were observed
in comparisons of CM and DC-HAIF cultures (R2 select [	0.99
conﬁdence level] 
 0.928), as well as in early- and late-passage
DC-HAIF cells (R2 select 
 0.959) (Figure 4B). Hierarchic
clustering analysis demonstrated that BG02 cells maintained in
DC-HAIF grouped tightly and retained a close similarity to
BG02 and BG03 cells maintained in CM (Figure 4C).These data
are consistent with previous analyses showing that undifferenti-
ated hESCs clustered tightly compared with embryoid bodies or
ﬁbroblasts.18 Analysis of micro-RNAs (miRNAs) demonstrated
expression of a core set of markers that form a characteristic
signature in undifferentiated hESCs (J.C. and M.R., submitted
manuscript) at the same or higher levels in cells grown in
DC-HAIF compared with CM (not shown). Finally, methylation-
speciﬁc PCR of a subset of CpG sites that distinguish hESCs
from other cell types27 indicated that BG02 cells maintained in
CM or DC-HAIF exhibited a similar methylation proﬁle (not
shown), which was clearly different from cancer cells and
differentiated cell types.27 To assess the developmental potential
of hESCs maintained in DC-HAIF, cultures were differentiated
to representatives of the 3 germ layers both in vivo and in vitro.
BG02 cells cultured in DC-HAIF for 6 months (25 passages)
maintained the potential to form complex teratomas containing
ectoderm, mesoderm, and endoderm (Figure 5A). Differentia-
tion to cells expressing III tubulin, smooth-muscle actin, or
-fetoprotein was demonstrated in embryoid bodies in vitro
(Figure 5B). Finally, modiﬁcation of a directed differentiation
approach28 enabled the generation of deﬁnitive endoderm and
foregut endoderm from hESCs using deﬁned medium conditions
(Figure 5C,D). These analyses demonstrated the stable mainte-
nance of key characteristics of pluirpotency and validated
DC-HAIF as a simple medium for supporting self-renewal.
Discussion
This study highlights IGF1R and ERBB2 as 2 previously unappreciated
RTKs that are essential for hESC self-renewal, enabling the develop-
ment of a deﬁned medium for hESC culture. While previous reports
have suggested several factors that may inﬂuence self-renewal in the
background of KSR-containing medium, relatively few studies have
demonstrated the successful expansion of undifferentiated hESCs under
deﬁned conditions.10,11,13,29 These deﬁned approaches also contained
high concentrations of insulin, present in the N2 or B27 medium
supplements, or added as a generic “survival factor.” Insulin is a potent
growth factor that can bind either IR or IGF1R and signal through the
PI3 kinase/AKT pathway, and the presence of insulin in the vast
Table 1. Summary of cytogenetic analyses of BG01 and BG02
DC-HAIF cells
Line
Passage no.
Karyotype (normal/total) Total HAIF
BG01 32 6 46,XY(20/20)
41 18 46,XY(19/20)*
BG02 47 5 46,XY(20/20)
61 19 46,XY(20/20)
71 26 46,XY(20/20)
*One metaphase exhibited an additional human chromosome 16.
Figure 4. Comparison of the transcriptome of hESCs maintained in DC-HAIF or CM. (A) Venn diagram of the distribution of transcripts detected using high-density Illumina
Sentrix Human-6 Expression Beadchips containing 47 296 transcript probes in BG02 cells maintained in CM (64 passages) or DC-HAIF (10 or 32 passages in deﬁned
medium).Alarge proportion of the expressed transcripts were detected in all samples. (B) Scatterplot analysis demonstrated that the transcriptional proﬁle of BG02 DC-HAIF
p32 cells was highly similar to that of BG02 cells maintained in CM (top panel), and was not substantially altered in early- and late-passage cultures in DC-HAIF (bottom panel).
Correlation coefﬁcients (R2) were generated using all detected transcripts with an expression level of more than 0 (black and blue dots), or with transcripts exhibiting a detection
conﬁdence level of more than 0.99 (R2 select, blue dots). Red lines delineate the mean and limits of a 2-fold difference. (C) Hierarchic clustering dendrogram of relative gene
expression in different populations generated using the Beadstudio software (Illumina, San Diego, CA). Early- and late-passage BG02 cells maintained in DC-HAIF clustered
tightly (approximately 0.0075) and retained a close similarity to BG02 and BG03 cells maintained in CM (approximately 0.037). Previous analyses showed that different
undifferentiated hESC lines clustered tightly (approximately 0.032) compared with differentiated embryoid body populations (approximately 0.0875) or ﬁbroblasts
(approximately 0.160).18
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IGF1R/IR signaling for the maintenance of hESCs. While the roles of
IR and IGF1R signaling were not distinguished in this study, our
ﬁndings suggest that IGF1R plays an important role because (1) the
speciﬁc IGF1R blocking antibody A12, which does not inhibit IR,25
reduced hESC proliferation and promoted differentiation; and
(2) hESCs transduced with a shRNA speciﬁc for IGF1R could not
sustain self-renewal.
While both NCM and CM contain high concentrations of
insulin, only CM supports the long-term culture of hESCs,2
suggesting that insulin-initiated IR and IGF1R signaling and low
levels of FGF2 are not sufﬁcient to maintain self-renewal. CM
elicited a proﬁle of RTK phosphorylation in hESCs that suggested
MEFs produce EGF family ligands. This is consistent with the
capacity of HRG to support pluripotency in deﬁned conditions.
Like other EGF family members, HRG is ﬁrst expressed as a
transmembrane protein, and is cleaved to various bioactive soluble
ectodomains by ADAM proteases.23 HRG binds to ERBB3 via its
EGF domain, and ERBB3 heterodimerizes with ERBB2. ERBB3
does not have a functional tyrosine kinase domain, and is phosphor-
ylated in trans by ERBB2.22 The role of HRG-ERBB2/3 signaling
in self-renewal points to other potential features of pluripotent
cells. Because hESCs grow as polarized epithelia30 and are
regulated by EGF family pathways, other mechanisms in the
regulation of epithelia may also be relevant. Interestingly, inappro-
priate activation of ERBB2 is associated with transformation of
multiple types of epithelial tissues.22 Duplication of ERBB2 at
17q21.1, trisomies of chromosome 17q, or overexpression of
ERBB2 or HRG are transforming events in breast cancer and other
tumors. Selective advantage and overgrowth of hESCs bearing
trisomies of chromosomes 17 (ERBB2) and 12 (ERBB3 at 12p13)
have been reported by several laboratories,31 raising the possibility
that similar mechanisms of transformation occur in hESCs and
epithelial tissues. ERBB2 is also part of a cohort of genes that
display a diagnostic methylation proﬁle that distinguishes pluripo-
tent cells from other cell types,27 implying tight epigenetic
regulation of this gene in the undifferentiated state. Finally, HRG
has been shown to support the expansion of mouse primordial germ
cells, a pluripotent cell type highly related to ESCs.32 These data
are all suggestive of a wider functional role of HRG and ERBB2/3
signaling in the self-renewal of pluripotent cells.
Signaling through the PI3 kinase/AKT pathway has recently been
implicatedintheself-renewalofmouse,primate,33andhumanESCs.34,35
Critically, inhibition of signaling through this pathway using the
Figure 5. In vivo and in vitro differentiation of hESCs maintained in DC-HAIF. (A) Analysis of teratomas from BG02 DC-HAIF p25 cells demonstrated pluripotent
differentiation potential to ectoderm, mesoderm, and endoderm. NSE indicates neuron-speciﬁc enolase; SMA, smooth-muscle actin; and pCK, pan-cytokeratin. Scale bars
equal 20 m (NSE, p63, 100 oil objective), 50 m (SMA, Ducts, pCK, 20 objective), and 200 m (Bone, 10 objective). (B) Differentiation of BG02 DC-HAIF p5 cells to
ectoderm (III tubulin), mesoderm (SMA), and endoderm (alphafetoprotein [FP]) lineages in embryoid bodies (20 objective, same scale as panel D). (C,D) Directed
differentiation of BG02 DC-HAIF p48 cells (HAIF) to deﬁnitive endoderm (d3) and foregut endoderm (d6) using deﬁned medium differentiation conditions (Document S1).
(C) qPCR analyses showed down-regulation of OCT4 expression and minimal PAX6 or CDX2 expression in differentiated samples, suggesting differentiation of pluripotent
cells and lack of substantial neuroepithelial or trophectodermal differentiation. The generation of deﬁnitive endoderm at day 3 was conﬁrmed by up-regulation of SOX17,
CXCR4, and CER expression, and foregut endoderm at day 6 by up-regulation of FOXA2, HNF1, and HNF4. Similar results were observed with CyT49 cells. Error bars are
plus or minus SD. (D) Immunostaining analyses conﬁrmed homogenous expression of OCT4 and lack of SOX17 expression in undifferentiated cultures (HAIF). After 3 days,
most cells express SOX17 with only pockets of OCT4 cells remaining (d3). After 6 days, the differentiation to foregut endoderm was conﬁrmed by expression of HNF1 and
HNF4 (d6). Only rare OCT4 cells were present at d6 (not shown). Scale bar equals 50 m (20 objective).
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(AKT1 inhibitor) induced differentiation of hESCs.34 Treatment of
hESCs with LY294002 was associated with a rapid collapse in
phosphorylation of AKT1, pS6, pS6K/p70, and GSK3.35 We have
conﬁrmed the importance role of this pathway by demonstrating that
1 to 20 nM rapamycin, an inhibitor of FRAP1 (mTOR), severely
restricted the proliferation of hESCs in DC-HAIF and induced differen-
tiation in short term culture (not shown). Because the PI3 kinase
pathway delivers both strong proliferative and antiapoptotic signals,
IR/IGF1R signaling should not be overlooked when interpreting the
effects of factors that feed into this common pathway, including FGF2,
PDGF, and neurotrophins.3,7,9,11 PI3 kinase signaling leads to the
activation of AKT and AKT-mediated inhibition of GSK3, and
therefore the presence of insulin also complicates the interpretation that
small-molecule inhibitors of GSK3are mimicking the effects ofWNT
signaling.8 It is possible that multiple inputs are required for appropriate
signaling and regulation of self-renewal through PI3 kinase in hESCs,
which in this study was driven by activation of IR, IGF1R, and
ERBB2/3.
This study identiﬁed IGF1R and ERBB2 as RTKs involved in
self-renewal of hESCs and enabled the development of a deﬁned
medium based around activation of these receptors. We have used
this strategy to demonstrate the capacity for large-scale expansion
of undifferentiated hESCs. A starting conﬂuent culture of BG02
cells in one 60-mm plate was expanded in DC-HAIF through
4 passages over 20 days to generate more than 1010 cells (T.S.,
A.R., unpublished data, December 2006). The ability to massively
expand undifferentiated hESC cultures, coupled with effective
differentiation approaches that also use deﬁned conditions to
generate clinically relevant populations,28 lays important ground-
work for eventual clinical applications.
Note added in proof: A requirement for IGF1R signaling in
hESC self-renewal was also reported by another group36 while this
manuscript was under review.
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